Indivior Pharmaceuticals, Inc. logo

Indivior Pharmaceuticals, Inc. (INDV)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
32. 45
-1.17
-3.4801%
$
4.19B Market Cap
- P/E Ratio
- Div Yield
4.29M Volume
1.35 Eps
$ 33.62
Previous Close
Add Transaction
Day Range
32.31 33.84
Year Range
23.72 42.81
Want to track INDV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Indivior Pharmaceuticals, Inc. (INDV) Statistics

Valuation metrics

Market Cap 4.19B
Enterprise value 4.34B
Trailing P/E (ttm) 11.43
Forward P/E 9.65
PEG ratio 0.06
Price/Sales (ttm) 3.04
Price/Book (mrq) -19.56
Enterprise Value/Revenue 3.26
Enterprise Value/EBITDA 9.92

Overview

Shares outstanding 122M
Float 103.78M
Shares short 12.82M
% Held by insiders 0.01%
% Held by institutions 1.05%
Average volume (10 days) 3.29M
Average volume (90 days) 2.31M

Price summary

52-Week low 23.72
52-Week high 42.81
Beta 1.2
50-Day moving average 35.19
200-Day moving average 36.82

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Jul 2016
Ex-Dividend Date 16 Jun 2016
Last split factor 1:5
Last split Date 10 Oct 2022

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.27%
Operating margin 0.39%

Operational effectiveness

Return on assets 0.29%
Return on equity -2.16%

Income Statement

Revenue (ttm) 1.29B
Revenue per share (ttm) 10.63
Quarterly revenue growth (yoy) 0.19%
Gross profit (ttm) 1.1B
EBITDA 374M
Net income to common (ttm) 252M
Diluted EPS (ttm) 2.83
Quarterly earnings growth (yoy) 0.89%

Balance Sheet

Total cash (mrq) 175M
Total cash per share (mrq) 1.77
Total debt (mrq) 509M
Total Debt/Equity (mrq) -2.45
Current ratio (mrq) 0.84%
Book value per share (mrq) -1.66

Cash Flow

Cash flow statement -111M
Levered free cash flow (LFCF) 44.25M